Dulce Digital-Me: An Adaptive mHealth Intervention for Underserved Hispanics With Diabetes

Summary

This study will compare Dulce Digital (i.e., the investigators' proven-effective combination of "one-size-fits-all" educational text messages and nurse monitoring of patient-transmitted blood glucose values) and Dulce Digital-Me (DD-Me), an adaptive/dynamic mHealth (mobile health) intervention that is tailored to individuals' needs and behavioral progress, in improving diabetes clinical control, adherence, and patient-provider communication in Hispanics - an at-risk, understudied population that experiences disparities in diabetes prevalence and outcomes. These striking disparities in the growing and aging US Hispanic population have taxed the US healthcare system, while significantly reducing quantity and quality of life for millions of individuals. By offering an innovative, scalable, and sustainable approach that seamlessly integrates several mHealth technologies into existing primary care team processes to improve the health of Hispanics (and eventually, other at-risk, underserved groups), DD-Me has strong potential to significantly impact public health.

Conditions

• Diabetes Mellitus, Type 2

Interventions

BEHAVIORAL

Dulce Digital

One-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values.

BEHAVIORAL

Dulce Digital-Me (Automated Delivery)

Educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes.

BEHAVIORAL

Dulce Digital-Me (Medical Assistant)

Educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes.

Sponsors & Collaborators

• University of California, San Diego

  collaborator OTHER

• San Diego State University

  collaborator OTHER

• Scripps Whittier Diabetes Institute

  lead OTHER

Principal Investigators

• Athena Philis-Tsimikas, MD · Scripps Whittier Diabetes Institute

• Linda Gallo, PhD · San Diego State University

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2017-10-31

Primary Completion

2021-08-14

Completion

2021-08-14

Countries

• United States

Study Locations